Antiangiogenic Activity of Aganirsen in Nonhuman Primate and Rodent Models of Retinal Neovascular Disease After Topical Administration

Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.11-9064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Related search

A Nonhuman Primate Model of Inherited Retinal Disease

Journal of Clinical Investigation
Medicine
2019English

Neuroprotective Activity of Curcumin Nanocarriers in Rodent Models of Retinal Injury

Acta Ophthalmologica
MedicineOphthalmology
2018English

Nonhuman Primate Models in Translational Regenerative Medicine

Stem Cells and Development
Developmental BiologyHematologyCell Biology
2014English

Nonhuman Primate Models of Social Behavior and Cocaine Abuse

Psychopharmacology
Pharmacology
2012English

The Role of Nonhuman Primate Models in the Development of Cell-Based Therapies for Parkinson’s Disease

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2017English

Evaluation of Topical Curcumin Nanoparticles in of Rodent Glaucoma Models

Acta Ophthalmologica
MedicineOphthalmology
2018English

Rabbit and Nonhuman Primate Models of Toxin-Targeting Human Anthrax Vaccines

Microbiology and Molecular Biology Reviews
Molecular BiologyInfectious DiseasesImmunologyMicrobiologyMicrobiology
2004English

S13.1: Nonhuman Primate Models of Pathogen Responses at the Maternal‐fetal Interface.

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Nonhuman Primate Model of Β-Amyloid (Aβ)-Induced Alzheimer's Disease (AD)

Science-Business eXchange
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy